Back The Synflora project, granted the Celebrate Innovation Award
The Synflora project, granted the Celebrate Innovation Award
The project consists of a platform that uses biotechnology to adapt microorganisms that release active compounds to improve acne-prone skin disorders.
Last week, the pharmaceutical company Cantabria Labs delivered the Celebrate Innovation Awards. The initiative aims to reward transformative and needs-specific solutions in the field of health.
One of the projects selected was the project “Synflora”, invented by the research group in Translational Synthetic Biology (SYNBIO) of the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, recognized in the Acne category. As Marc Güell, head of SYNBIO, explains, “Synflora consists of a platform that uses biotechnology to adapt microorganisms that release active compounds to improve acne-prone skin disorders”.
“Synflora consists of a platform that uses biotechnology to adapt microorganisms that release active compounds to improve acne-prone skin disorders”
Nastassia Knödlseder, a member of the research team, states that “Synflora can produce and supply long-term therapies within the skin, and they are precise and target the site of interest. Our technology enables treating skin diseases by leveraging the capabilities of nature and the necessary efforts of genetic engineering”.
The winning proposals of each category received a cash prize and the possibility of developing their project with the help of Cantabria Labs. All the initiatives were based on the pillars of innovation, sustainability and development potential, with a view to improving people’s quality of life. The projects have provided inspirational ideas that will encourage the development of products or therapeutic areas, through diagnostics, wearables, artificial intelligence projects or the development of molecules and ingredients to thus help people improve through science.
An Evaluation Committee composed of representatives of Cantabria Labs, dermatologists, opinion leaders, university full professors specializing in different areas and institutions, undertook to evaluate, examine the various projects and select the most innovative proposals.
The other winners were: in the category of Photobiology, Jesús Espada, senior researcher at Hospital La Pau Institute for Health Research (IdiPAZ) and founder/CSO/principal investigator at Skin Target BD SL, and Kristie Tanner, project manager at Darwin Bioprospecting Excellence, with a new photoprotector based on combinations of existing pigments in extremophilic microorganisms.
In the Dermatology section, the project by Dolores Serrano, a researcher at the Complutense University of Madrid, was awarded. And finally, the D. José Antonio Matji Special Prize in Immunology was awarded to Olga Durany Turk, CEO/CTO at GAT Biosciences.